The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

Monoclonal antibodies are immune system proteins that ... Of those who did pay out-of-pocket costs, 80% paid between $0.01 and $925 per infusion, after paying the deductible.

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody treatment shown to slow cognitive decline in ...

Enhertu (fam-trastuzumab deruxtecan-nxki) can cause side effects that range from mild ... treatment starts before you receive an Enhertu infusion and continues a few hours after.

In general, the infusion ... side effects, as they are highly toxic. These drugs can also be taken orally. Other cancer therapies, such as immunotherapies and targeted therapies, use monoclonal ...

Mounjaro can cause side effects that range from mild to serious. The most common side effects include nausea, diarrhea, and decreased appetite. Mounjaro (tirzepatide) is prescribed to help manage ...

"Some researchers believe that repeated exposure to false information can cause people to not get vaccinated, while others believe the effect is relatively weak because it would only allow them to ...

are also associated with an increased risk of several negative health outcomes and side effects. The most common were the well-known gastrointestinal problems, such as nausea, vomiting ...